FDA NDC Directory · JSON-LD · Markdown

Orphenadrine Citrate, Aspirin and Caffeine

NDC 71993-304 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAtland Pharmaceuticals, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA075141
Dosage form / routeTABLET · ORAL
Active ingredientsASPIRIN (385 mg/1)
CAFFEINE (30 mg/1)
ORPHENADRINE CITRATE (25 mg/1)
Marketing started20220318
Package count1

External sources

Source: openFDA. Public-domain (CC0).